Skip to content

Effects of Exercise and 5-HTP on Cortisol Levels

Effects of Exercise and 5-HTP on Cortisol Levels

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02187341
Enrollment
12
Registered
2014-07-11
Start date
2014-06-30
Completion date
2015-12-31
Last updated
2014-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plasma Cortisol

Brief summary

It has been shown that 5-HTP stimulates cortisol levels in plasma and saliva. Similarly, it has been shown that intense exercise stimulates an increase in plasma and salivary cortisol levels. The purpose of this study is to examine the combined effects of 5-HTP + intense exercise on plasma and salivary cortisol levels.

Interventions

DIETARY_SUPPLEMENT5-HTP

Volunteers participate in two visits at least 5 days apart . The day of their visit they ingest (2 hours before reporting to the laboratory) either a capsule containing 200 mg of 5-HTP or a capsule containing placebo (sugar pill). The order of the visits is randomized

DIETARY_SUPPLEMENTPlacebo

Volunteers participate in two visits at least 5 days apart . The day of their visit they ingest (2 hours before reporting to the laboratory) either a capsule containing 200 mg of 5-HTP or a capsule containing placebo (sugar pill). The order of the visits is randomized

Sponsors

Benedictine University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy men and women, not taking medication known to alter glucocorticoid metabolism

Exclusion criteria

* Diabetes * Obesity * Hypertension * Coronary artery disease * Psychiatric disorders * Any disease preventing them from participating in intense exercise * Subjects taking medication known to interfere with glucocorticoid metabolism will be excluded

Design outcomes

Primary

MeasureTime frameDescription
Change in plasma cortisol from baseline to 20 minutes postbaseline, 20 minPlasma cortisol will be assessed at baseline and 20 min post exercise and compared to baseline, and compared between treatments: 5-HTP vs placebo visit. The interventions are acute ( 1 dose, 1 day), for 5-HTP and for placebo, there is no follow up. The interventions are at least 1 week apart. For a given subject, the estimated time for study completion for the 2 treatments is 10 to 30 days

Secondary

MeasureTime frameDescription
Change in plasma cortisol from baseline to 5 minutes postbaseline, 5 minutesPlasma cortisol will be assessed at baseline and 5 min post exercise and compared to baseline, and compared between treatments: 5-HTP vs placebo visit. The interventions are acute ( 1 dose, 1 day), for 5-HTP and for placebo, there is no follow up. The interventions are at least 1 week apart. For a given subject, the estimated time for study completion for the 2 treatments is 10 to 30 days

Countries

United States

Contacts

Primary ContactPedro Del Corral, PhD-MD
pdelcorral@ben.edu630 8296575

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026